Skip to content

Train with us

Explore

StudentsStudent union partnership: your class fund
Sign upLog in

Morton's neuroma (Morton's metatarsalgia)

Morton's neuroma: a perineural fibrosis rather than a tumour, Mulder's sign, high-resolution ultrasound, footwear, a metatarsal dome and injections.

Posted by

Anthony BAILLON

Physiotherapist

Physiotherapy · Foot & ankle

In brief

Morton's neuroma, or Morton's metatarsalgia, is not a tumour but a perineural fibrosis of the common plantar digital nerve, secondary to chronic compression under the deep transverse intermetatarsal ligament, sitting above all in the 3rd intermetatarsal space. The typical pain is a burning or an electric shock in the forefoot, made worse by tight shoes and relieved by taking the shoe off and by massage; the diagnosis stays clinical, helped by Mulder's sign (highly specific) and by high-resolution ultrasound. The first line combines a change of footwear (a wide toe) and a foot orthosis with a metatarsal dome, with ultrasound-guided corticosteroid injections coming second. The female to male ratio is about 4:1.

A 2026 clinical synthesis on plantar interdigital entrapment neuropathy, based on the recent systematic reviews Pitcher 2024, Lu 2021, Matthews 2019, Bhatia 2020 and on 2023-2025 data.

Clinical diagnosis Mulder's sign Orthosis + ESWT Evidence-based
4:1
Female to male ratio
Bhatia 2020 · current concepts review
90%
Sensitivity of HR ultrasound
Bignotti 2015 · meta-analysis of 14 studies
74%
Pain resolution after neurectomy
Lu 2021 · MA of 35 studies, n=2998

Clinical synthesis

  • Morton's neuroma is not a tumour but a perineural fibrosis of the common plantar digital nerve, secondary to chronic compression under the deep transverse intermetatarsal ligament.
  • The main location is the 3rd intermetatarsal space (up to 60-70 % of cases), followed by the 2nd space. The female to male ratio is around 4:1, with a peak between 40 and 60 years.
  • Wearing shoes with a narrow toe and high heels is the main modifiable risk factor. Foot deformities (hallux valgus, pes planus, pes cavus) and high-impact sports also contribute.
  • Without a change in the mechanical stresses, the course is broadly progressive : the fibrosis organises and becomes less reversible with time.
  • The typical pain is a burning or an electric shock in the forefoot, made worse by tight shoes and relieved by taking the shoe off and by massaging the interdigital space concerned.
  • The Mulder sign (a palpable click on lateral compression + plantar pressure) has a very variable sensitivity (29-94 %) but a high specificity (87-100 %), so it is a confirmation test, not a screening one (Pitcher 2024).
  • High-resolution ultrasound is the first-line imaging: sensitivity 90 % / specificity 88 % (Bignotti 2015). MRI is reserved for atypical cases or for excluding a stress fracture or Freiberg's disease.
  • The imaging-clinical correlation is imperfect : up to 33 % of compatible images are asymptomatic (Bencardino 2000). The diagnosis must stay fundamentally clinical.
  • The essential differential diagnosis covers intermetatarsal bursitis, stress fracture, MTP capsulitis or synovitis, Freiberg's disease, L5-S1 radiculopathy and tarsal tunnel syndrome.
  • 1st line treatment: a change of footwear (a wide toe) + a foot orthosis with a metatarsal dome placed behind the metatarsal heads. Saygi 2005, a randomised trial: 63 % complete or partial relief at 12 months with suitable footwear and orthoses.
  • 2nd line: ultrasound-guided corticosteroid injections, effective in the short and medium term (Choi 2021), with a limited risk of fat pad atrophy. Alcohol sclerosis is less solidly supported and riskier.
  • Emerging options: ESWT (moderate evidence of efficacy) and above all pulsed radiofrequency (SR/MA 2025, 8 studies, 237 patients): a significant VAS reduction at the last follow-up, 47.6 % complete pain relief and 16.4 % of patients with no benefit at all.
  • Surgery (neurectomy) as a last resort: success ≈ 74 % but a risk of a recurrent stump neuroma ≈ 14 % (Lu 2021, MA of 2,998 patients).
  • Strengthening the intrinsic foot muscles, stretching the gastrocnemius (DiGiovanni 2002) and working the posterior chain are logical additions in physiotherapy.
  • Specific red flags: a firm or painless swelling, non-mechanical night pain, a history of cancer, a wound or ulceration, fever, all call for immediate referral (Finucane 2020).
  • Measure outcomes with validated PROMs (MOXFQ, FFI, AOFAS, VAS) and engage in shared decision-making (Légaré 2018) before any move to injection or surgery.

Contents

  1. What are the fundamentals to know about Morton's neuroma?
    1. How is this condition defined, who is affected and what are the risk factors?
    2. What happens in the body and how does Morton's neuroma evolve naturally?
  2. How do you assess and diagnose Morton's neuroma with confidence?
    1. Which questions should you ask to understand the patient and their history?
    2. Which clinical tests should you perform and which other conditions should you rule out?
    3. Should patients with Morton's neuroma be classified, and for what benefit?
  3. Why does Morton's neuroma mainly affect women, and what part does footwear play?
    1. What is the biomechanical impact of high heels and narrow shoes?
    2. How do you target prevention in the woman at risk?
  4. Which treatment strategies are the most effective for Morton's neuroma?
    1. Where do you start? What is the recommended hierarchy of interventions?
    2. What place does exercise hold and is there a superior approach?
    3. Manual therapy, shockwave, radiofrequency: how effective are they really?
    4. Beyond the physical: how do you educate the patient and address psychological factors?
  5. How do you secure a lasting recovery and prevent recurrence in Morton's neuroma?
    1. How do you make the patient an active player in their own recovery through self-management?
    2. When and how do you plan a safe return to sport and to activity?
  6. What do real clinical cases teach us about Morton's neuroma?
    1. Analysis of a « classic » case: from assessment to conservative resolution.
    2. The diagnostic challenge: when Morton's neuroma mimics another condition.
    3. A complex case: stump recurrence and multiple forms.
  7. How do you apply these recommendations concretely in your practice?
    1. When, and to which other health professionals, should you refer?
    2. How do you measure outcomes and overcome the barriers to implementation?

What are the fundamentals to know about Morton's neuroma (Morton's metatarsalgia)?

In this chapter: the contemporary definition of interdigital entrapment neuropathy (the word « neuroma » is misleading), consolidated epidemiology (F:M ratio 4:1, peak 40-60 years), mechanical and anatomical risk factors, pathophysiology (chronic compression, ischaemia, perineural fibrosis), and the progressive natural trajectory without a change in the stresses.

How is this condition defined, who is affected and what are the risk factors?

Morton's neuroma, also called Morton's metatarsalgia or, more precisely, interdigital entrapment neuropathy, is a painful mechanical condition of the forefoot. Despite its historical name, it is neither a true nerve tumour nor a neoplastic process, but a perineural fibrosis of the common plantar digital nerve secondary to chronic compression under the deep transverse intermetatarsal ligament.¹٬² The alternative terms used in the literature include « interdigital neuralgia », « interdigital nerve entrapment syndrome », « Civinini-Morton syndrome » and « intermetatarsal neuroma ».² The preferred location is, by a long way, the 3rd intermetatarsal space (between the heads of the 3rd and 4th metatarsals), followed by the 2nd space.² Involvement of the 1st and of the 4th space is exceptional.³ The local anatomy explains this predilection: at that level the common plantar digital nerve receives an anastomosis from the lateral plantar nerve, which creates an anatomical thickening vulnerable to compression.² Epidemiologically 👱‍♀️:
  • The female to male ratio is around 4:1 in the English-language clinical series.²
  • The incidence peaks between 40 and 60 years, the period of peak exposure to heeled and narrow shoes combined with a loss of tissue suppleness.²٬⁴
  • An incidental finding on imaging is frequent : Bencardino et al. showed, on 57 MRI examinations, that about 33 % of people with no clinical complaint had an image compatible with a Morton's neuroma.⁵
4:1Female to male ratio (clinical series)
3rdThe most affected intermetatarsal space
40-60Age band of peak incidence
33 %Compatible images in asymptomatic people (Bencardino 2000)

📊 Distribution of Morton's neuromas by intermetatarsal space

Data pooled from the main clinical series (Bhatia 2020, Munir 2023, Di Caprio 2018)

Morton distribution by intermetatarsal space 70% 50% 30% 10% 0% ≈ 65 % 3e space ≈ 30 % 2e space < 5 % 1st & 4e

Sources: Bhatia M & Thomson L. J Clin Orthop Trauma. 2020; Munir U et al. StatPearls. 2023; Di Caprio F et al. Foot Ankle Surg. 2018.

The risk factors are mainly mechanical and extrinsic. The best documented is the wearing of shoes with a narrow toe and high heels, which combines two stresses: hyperextension of the metatarsophalangeal (MTP) joints (putting the common plantar digital nerve under maximum tension beneath the deep transverse ligament) and lateral compression of the forefoot (narrowing the interdigital space).¹٬²٬⁴ This combination explains the strong female predominance. Other factors contribute to varying degrees:
  • Structural foot deformities 🦶: hallux valgus (often associated), hammer toes, pes planus (flat foot) or, conversely, a markedly cavus foot. These deformities change the load distribution and increase interdigital compression.²٬⁴
  • High-impact or repetitive activities 🏃‍♀️: running (on hard ground in particular), dance (classical dance on demi-pointe above all), jumping sports. The mechanisms invoked are repeated MTP hyperextension and microtrauma to the nerve.²
  • Laxity of the transverse ligament : forefoot instability that increases the shear stresses on the digital nerve.⁴
  • Obesity or excess weight : raises forefoot plantar pressures with every step and can speed up the fibrosis.⁶

⚖️ Hierarchy of the mechanical risk factors (2026 narrative review)

Approximate strength of association, the relative risk estimated against the general population (an indicative range, no formal meta-analysis available)

Mechanical risk factors for Morton's neuroma RR=1 (ref) 2 4 6 8 High heels + narrow toe ~6-8× Intensive running / dance ~3-4× Hallux valgus ~2-3× Marked pes cavus ~2× Excess weight ~1.5×

⚠️ Narrative estimates from clinical series and reviews, with no formal meta-analysis available for these factors. Sources: Bhatia 2020, Munir 2023, Lizano-Díez 2019.

« The word "neuroma" is a misleading histological legacy. The condition is neither tumoral nor proliferative: it is a chronic compressive neuropathy whose treatment aims first at removing the mechanical stress that keeps it going. »

What happens in the body and how does Morton's neuroma evolve naturally?

The pathophysiology of Morton's neuroma rests on a cycle of chronic compression and repeated microtrauma of the common plantar digital nerve, where it passes under the deep transverse intermetatarsal ligament.¹٬² The anatomical space there is very tight and any local rise in pressure starts a stereotyped pathological sequence. 🔬 That sequence covers:
  1. Mechanical compression from MTP hyperextension, a narrow shoe, and crushing between the metatarsal heads.
  2. Local ischaemia : the pressure reduces the blood supply from the vasa nervorum.¹
  3. An inflammatory reaction with intra-epineural oedema, further increasing the volume in that confined space.²
  4. Perineural fibrosis : proliferation of dense connective tissue by the fibroblasts in response to the chronic trauma. It is this fibrous thickening that makes up the « neuroma ».¹٬²
  5. A vicious circle : the fibrosis increases the diameter of the nerve, making it more liable to compression, so the condition sustains itself.²
Histopathological analysis of the surgical specimens shows a marked thickening of the perineurium and of the endoneurium, hyalinisation of the walls of the vasa nervorum, axonal demyelination and a loss of myelinated nerve fibres.¹ The anatomical work of Stecco et al. (2015, J Anat) clarified the role of the deep plantar fascia and of the superficial aponeurosis in transmitting the stresses: a thickened aponeurosis can worsen the compression both above and below the nerve.⁷

🔁 The pathophysiological vicious circle of Morton's neuroma

A self-sustaining loop when the initial mechanical stress is not corrected

Pathophysiological vicious circle in Morton 1. Chronic mechanical compression 2. Local ischaemia ↓ vasa nervorum 3. Inflammation oedema, cytokines 4. Perineural fibrosis progressive thickening

Without a change in the initial mechanical stress, the vicious circle sustains itself and the fibrosis becomes progressively irreversible. Sources: Bhatia 2020, Munir 2023.

The natural history without treatment remains imperfectly described (few prospective longitudinal studies are available). It is generally accepted, however, that the condition is progressive when the mechanical factors are not changed.²٬⁴ At first the symptoms may be intermittent, triggered only by certain shoes or activities. Without intervention, the episodes become more frequent, more intense and eventually constant. With time the fibrosis organises and becomes less reversible, making conservative treatment less effective.²

Key points

  • Morton's neuroma is not a tumour but a perineural fibrosis of the common plantar digital nerve secondary to chronic mechanical compression.
  • Main location: 3rd intermetatarsal space, ratio 4:1 female to male, peak 40-60 years.
  • The dominant and modifiable risk factor: narrow high-heeled shoes (a major biomechanical impact).
  • Mechanism: a vicious circle of compression → ischaemia → inflammation → fibrosis → ↑ volume → ↑ compression.
  • 33 % of compatible images are asymptomatic (Bencardino 2000), so the diagnosis stays above all clinical.
  • Without a change in the stresses, the course is progressive and the fibrosis becomes less reversible with time.
Bibliography
  1. Munir U, Tafti D, Morgan S. Morton Neuroma. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; updated 2023 May. NBK470249.
  2. Bhatia M, Thomson L. Morton's neuroma — Current concepts review. J Clin Orthop Trauma. 2020;11(3):406-409. PMID 32405199.
  3. Di Caprio F, Meringolo R, Shehab Eddine M, Ponziani L. Morton's interdigital neuroma of the foot: A literature review. Foot Ankle Surg. 2018;24(2):92-98. PMID 29409221.
  4. Lizano-Díez X, Ginés-Cespedosa A, Alentorn-Geli E, Pérez-Prieto D. Morton's interdigital neuroma: instructional review. EFORT Open Rev. 2019;4(1):14-24. doi:10.1302/2058-5241.4.180025.
  5. Bencardino J, Rosenberg ZS, Beltran J, Liu X, Marty-Delfaut E. Morton's neuroma: is it always symptomatic? AJR Am J Roentgenol. 2000;175(3):649-653. PMID 10954445.
  6. Jain S, Mannan K. The diagnosis and management of Morton's neuroma: a literature update. Foot Ankle Spec. 2013;6(4):307-317. PMID 23811947.
  7. Stecco C, Fantoni I, Macchi V, et al. The role of fasciae in Civinini-Morton's syndrome. J Anat. 2015;227(5):654-664. PMID 26467241.

How do you assess and diagnose Morton's neuroma with confidence?

In this chapter: a structured history (the specific pain features), validated clinical tests with an updated level of evidence (Mulder's sign according to the Pitcher 2024 review), the essential differential diagnosis (stress fracture, bursitis, Freiberg, capsulitis), a clinical classification for stratifying treatment, and a critique of the imperfect imaging-clinical correlation.
Assessing Morton's neuroma is an exercise in structured clinical reasoning. The diagnosis must stay fundamentally clinical : imaging serves only to confirm a strong suspicion or to rule out a differential diagnosis.¹٬² The systematic review by Pitcher et al. (2024) on the diagnostic accuracy of the subjective features and of the physical examination confirms that combining several coherent clinical elements has a better predictive value than any test on its own.³

Which questions should you ask to understand the patient and their history?

The history aims to reconstruct the typical symptom picture of an interdigital compression neuropathy. The elements to look for actively are:
  • Characteristics of the pain : burning, shooting, cramping or an electric shock in the forefoot, most often in the 3rd intermetatarsal space. A highly suggestive sensation of « walking on a pebble » or on a fold in a sock.¹٬² Sometimes with paraesthesia (numbness or pins and needles) radiating towards the 3rd and 4th toes.
  • Aggravating factors 👠: wearing tight shoes with a narrow toe or high heels; prolonged walking; sporting activities with repeated impact.²
  • An almost pathognomonic relieving factor : taking the shoe off and massaging the forefoot bring rapid relief. That information alone points strongly to the diagnosis.²٬⁴
  • Time course : an often insidious onset, symptoms intermittent at first and then more and more frequent. Assess the duration, the functional impact and the disability felt (the FFI or MOXFQ questionnaire is useful).⁵
  • Relevant history : known foot deformities (hallux valgus, hammer toes), previous trauma, a standing occupation, the sport played (running or dance), footwear habits.

Which clinical tests should you perform and which other conditions should you rule out?

The clinical examination combines inspection, palpation and provocation tests. Inspection may reveal a collapse of the transverse arch or an associated deformity, but often contributes little.² Direct palpation of the suspected interdigital space (from the plantar side, sliding the thumb into the space) typically triggers a localised pain. Three provocation tests are used in practice:
  1. Lateral compression test (squeeze test) : mediolateral pressure applied with one hand across the forefoot. Positive if it reproduces the neuralgic pain. Variable sensitivity, poorly specific.
  2. Mulder test : combines lateral compression + plantar pressure from the thumb in the interdigital space. A palpable click (sometimes audible) reproducing the pain marks a positive test. It is the best known and the most taught test.¹٬⁶
  3. Dorsoplantar test (« thumb-index finger squeeze »): targeted dorsoplantar compression of one intermetatarsal space, less studied but useful in addition.²
⚠️ The real diagnostic accuracy of Mulder's sign : the recent systematic review by Pitcher et al. (2024) reports a very variable sensitivity (29-94 %) and a high specificity (87-100 %) across the studies.³ The highest positive likelihood ratio (LR+) described is 2.19 (Dando), a value considered weak but useful evidence. The clinical meaning is therefore this: a positive Mulder raises the probability of Morton; a negative Mulder does not rule it out. No physical test on its own has enough accuracy to confirm the diagnosis by itself.³

🎯 Diagnostic accuracy of the clinical tests (Pitcher 2024, systematic review)

Pooled sensitivity (Se) and specificity (Sp), with the range reported across the included studies for each test

Diagnostic accuracy of the clinical tests and imaging in Morton 25 % 50 % 75 % 100 % Mulder Se 29-94 % Mulder Sp 87-100 % Ultrasound Se 90 % Ultrasound Sp 88 % MRI Se 90 % MRI Sp ~100 % Key: light bar = sensitivity (Se), dark bar = specificity (Sp)

Sources: Pitcher M et al. Foot Ankle Orthop. 2024 (Mulder); Bignotti B et al. Eur Radiol. 2015 (US vs MRI, a meta-analysis of 14 studies).

The differential diagnosis is a critical step. Several conditions can mimic a Morton's neuroma:
  • Local conditions : intermetatarsal bursitis (often associated), metatarsal stress fracture, capsulitis or synovitis of an MTP joint, Freiberg's disease (osteonecrosis of the M2 head), flexor tenosynovitis.²٬⁶
  • Conditions at a distance : L5-S1 radiculopathy, tarsal tunnel syndrome, metabolic peripheral neuropathy (diabetes).²
  • Rare systemic conditions: osteomyelitis, bone tumour, soft tissue sarcoma, to be considered if there are red flags.

🚩 Red flags specific to the painful forefoot

  • Non-mechanical night pain, unrelieved by taking the shoe off → suspected malignancy, infection or a metabolic cause.
  • A firm, fixed, painless swelling or a progressive one → a tumour work-up (synovial sarcoma, schwannoma).
  • A wound, ulceration, marked inflammatory signs → infection (osteomyelitis, abscess), to be explored urgently in the person with diabetes.
  • Fever + forefoot pain → a deep infection.
  • A history of cancer + focal bone pain → suspected metastasis.
  • Unexplained weight loss + persistent pain → a cancer work-up.
  • Stocking hypoaesthesia + diffuse pain → peripheral neuropathy (diabetes, alcohol, toxic).

⚠️ Any red flag → prompt medical referral before any physiotherapy management. Reference: Finucane LM et al. JOSPT 2020.

When the clinical diagnosis stays uncertain, or to confirm it before an invasive procedure, high-resolution ultrasound is the first-line examination. 🩺 The meta-analysis by Bignotti et al. (2015, 14 studies) reports a sensitivity of 90 % and a specificity of 88 % for ultrasound, comparable with the performance of MRI (Se 90 %, Sp 100 %), with a major advantage in cost, availability and injection guidance.⁷ MRI is reserved for atypical cases, for suspicion of an alternative diagnosis (Freiberg, an occult fracture, a tumour) or when the ultrasound is inconclusive.

Should patients with Morton's neuroma be classified, and for what benefit?

There is no universally standardised classification for Morton's neuroma, but stratifying patients by severity has a major therapeutic value: avoiding overtreatment in early forms, and not delaying more intensive management in severe and disabling ones.²٬⁴ Two complementary approaches:
  1. A clinical classification by severity :
    • Mild : intermittent pain, triggered only by certain shoes, with no impact on daily life.
    • Moderate : frequent pain, limitation of some activities (sport, prolonged walking), recurrence in suitable shoes.
    • Severe : almost constant pain including barefoot, persistent paraesthesia, occupational or social impact, failure of well-conducted conservative treatment.
  2. An ultrasound classification by size : a size > 5 mm is often considered clinically significant and associated with a poorer response to conservative treatment.²٬⁸ Size alone must not dictate the strategy: an asymptomatic neuroma > 5 mm is still an asymptomatic neuroma.
The value of this stratification is to guide the treatment decision 🎯: a mild stage will probably respond well to 1st line measures (footwear + orthosis), while a severe stage justifies discussing the 2nd line options (injection, ESWT, radiofrequency) or even surgery from the outset.²

Criticism and controversies on the diagnosis

Three areas of controversy deserve to be spelled out: First, the imaging-clinical correlation is imperfect. Bencardino et al. found, in nearly 33 % of asymptomatic control subjects, an MRI image compatible with a Morton's neuroma.⁹ That means a diagnosis based on imaging alone is inadequate and can lead to unnecessary treatment. The presence of a « neuroma » on imaging does not imply that it causes the symptoms, so you must always correlate with the clinical picture.²٬⁹ Secondly, the word « neuroma » is a histological misnomer. A true neuroma would be a tumoral proliferation of nerve cells, which is not the case here. Histopathological analysis reveals perineural fibrosis and axonal degeneration, with no neoplastic proliferation.¹٬⁴ The more precise term would be « interdigital compressive neuropathy » or « perineural fibrosis ». Thirdly, the operator-dependent reliability of the clinical tests. The considerable variability in the sensitivity of Mulder's sign (29-94 %) illustrates a lack of standardisation in the examination.³ An inexperienced clinician can miss a subtle click or, conversely, read a tendon movement as positive. The real diagnostic accuracy depends as much on the examiner as on the test itself.³ A pragmatic conclusion: combine several coherent clinical elements (history + Mulder + pain on palpation) rather than relying on one test alone.

Key points

  • ✅ The diagnosis is fundamentally clinical : burning or electric-shock pain, made worse by tight shoes, relieved by taking the shoe off.
  • ✅ The Mulder sign is specific (87-100 %) but not very sensitive (29-94 %, Pitcher 2024): a negative test does not rule out the diagnosis.
  • ✅ Combining several coherent clinical elements (history + Mulder + focal palpation) remains the best diagnostic strategy.
  • ✅ High-resolution ultrasound (Se 90 % / Sp 88 %) is the confirmation examination of choice, MRI being reserved for atypical cases.
  • ✅ The imperfect imaging-clinical correlation means never treating an image without a symptom: ≈ 33 % of compatible images are asymptomatic (Bencardino 2000).
  • ✅ The differential diagnosis (bursitis, stress fracture, Freiberg, capsulitis, radiculopathy) is obligatory before any treatment decision.
Bibliography
  1. Munir U, Tafti D, Morgan S. Morton Neuroma. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; updated 2023 May. NBK470249.
  2. Bhatia M, Thomson L. Morton's neuroma — Current concepts review. J Clin Orthop Trauma. 2020;11(3):406-409. PMID 32405199.
  3. Pitcher M, Moulson A, Pitcher D, Herbland A, Cairns MC. Diagnostic Accuracy of Subjective Features and Physical Examination Tests for Morton Neuroma: A Systematic Review. Foot Ankle Orthop. 2024;9(4). doi:10.1177/24730114241291055.
  4. Lizano-Díez X, Ginés-Cespedosa A, Alentorn-Geli E, Pérez-Prieto D. Morton's interdigital neuroma: instructional review. EFORT Open Rev. 2019;4(1):14-24. doi:10.1302/2058-5241.4.180025.
  5. Pastides P, El-Sallakh S, Charalambides C. Morton's neuroma: A clinical versus radiological diagnosis. Foot Ankle Surg. 2012;18(1):22-24. PMID 22325999.
  6. Mahadevan D, Venkatesan M, Bhatt R, Bhatia M. Diagnostic accuracy of clinical tests for Morton's neuroma compared with ultrasonography. J Foot Ankle Surg. 2015;54(4):549-553. doi:10.1053/j.jfas.2014.09.021.
  7. Bignotti B, Signori A, Sormani MP, Molfetta L, Martinoli C, Tagliafico A. Ultrasound versus magnetic resonance imaging for Morton neuroma: systematic review and meta-analysis. Eur Radiol. 2015;25(8):2254-2262. PMID 25809742.
  8. Jain S, Mannan K. The diagnosis and management of Morton's neuroma: a literature update. Foot Ankle Spec. 2013;6(4):307-317. PMID 23811947.
  9. Bencardino J, Rosenberg ZS, Beltran J, Liu X, Marty-Delfaut E. Morton's neuroma: is it always symptomatic? AJR Am J Roentgenol. 2000;175(3):649-653. PMID 10954445.
  10. Finucane LM, Downie A, Mercer C, et al. International Framework for Red Flags for Potential Serious Spinal Pathologies. J Orthop Sports Phys Ther. 2020;50(7):350-372. PMID 32438853.

Why does Morton's neuroma mainly affect women, and what part does footwear play?

In this chapter: an analysis of the female-male epidemiological imbalance (a 4:1 ratio), the biomechanical mechanisms of the high-heeled and narrow-toed shoe, the impact on forefoot pressure, practical tools for assessing footwear in the consultation, and targeted prevention strategies. This dedicated section deals with the main modifiable variable of the condition.
The gap between men and women in Morton's neuroma is one of the most marked in the whole of forefoot pathology. Every major review agrees on a female to male ratio of around 4:1 in the clinical series, with some British hospital series reporting ratios reaching 8:1.¹ The typical age at presentation lies between 40 and 60 years, and about 70 % of patients are between 40 and 69 in the national hospital data.² This imbalance is not due to an intrinsic anatomical difference but essentially to a differential exposure to the mechanical stresses imposed by footwear.

What is the biomechanical impact of high heels and narrow shoes?

The women's shoe with high heels and a narrow toe combines three mechanical stresses that are directly harmful to the interdigital nerve:
  1. Hyperextension of the metatarsophalangeal (MTP) joints : an 8 cm heel imposes an MTP dorsiflexion of the order of 50-70°, which puts the common plantar digital nerve under maximum tension beneath the deep transverse intermetatarsal ligament.¹٬³
  2. Lateral compression from the narrow (« pointed ») toe: the metatarsal heads are pushed together, which physically narrows the space the nerve travels through.¹٬⁴
  3. Forward translation of body weight onto the forefoot: a 2.5 cm (1 inch) heel already raises forefoot pressure by about +22 %, and that rise is more than linear with heel height.⁵

📈 Rise in forefoot plantar pressure by heel height

An indicative estimate (against a flat foot), after the narrative reviews and baropodometric studies

Forefoot pressure by heel height 200% 175% 150% 125% 100% 75% 100 % Flat foot ≈ 122 % 2.5 cm ≈ 157 % 5 cm ≈ 176 % 7.5 cm ≈ 200 % 10 cm

⚠️ Indicative values from biomechanical reviews. For a personalised analysis: a baropodometric examination. Sources: Munir 2023, Bhatia 2020; a dose-dependent effect confirmed by biomechanical reviews on high heels.

The anatomical consequences are many: contractures of the posterior chain (shortening of gastrocnemius and soleus), a change in the foot strike (loss of the heel strike → forefoot impact from the contact phase), saturation of metatarsal heads 2-4. This chronic posture favours not only Morton's neuroma, but also hallux valgus, hammer toes, Freiberg's disease, propulsive metatarsalgia and stress fracture , all conditions epidemiologically more frequent in women exposed to these shoes.¹٬³
« Contemporary women's footwear is probably the most powerful chronic iatrogenic mechanical intervention observable in forefoot pathology. Conversely, it is also the most effective and most modifiable lever in preventing Morton's neuroma. »

How do you target prevention in the woman at risk?

A systematic assessment of footwear must be part of the minimum protocol of any physiotherapy consultation with a woman presenting with forefoot pain. Here is a condensed practical tool:
Criterion assessedRecommended targetMarker of raised risk
Heel height≤ 2.5 cm (1 inch)≥ 5 cm, risk ×2-3; ≥ 7.5 cm, risk ×4
Width of the toe boxToes flat with no compression, able to move freelyA pointed toe or a « fashionably narrow toe » compressing the metatarsal heads
Depth of the toe boxEnough depth for hammer toes or hallux valgusA flat toe preventing free MTP extension
Stiffness of the soleModerate, with the flex just at the MTP jointsA sole that is too soft (flexing at the midfoot) or too stiff throughout
Cushioning of the solePresent under the forefoot (EVA foam or similar)A hard leather-on-leather sole, hard ground (asphalt) with no cushioning
Midfoot holdLacing or a fastening that holds the base of the footMules, clogs, ballet flats: the foot slides forward with every step

🧭 An algorithm for intervening on footwear in the woman at risk

A pragmatic hierarchy of the changes to propose in the clinic

Footwear intervention algorithm in Morton Footwear audit (everyday + sport + work) Step 1, remove heels ≥ 5 cm from everyday wear Step 2, a wide toe box + forefoot cushioning Step 3, an orthosis with a metatarsal dome Step 4, gastroc stretching + intrinsic strengthening Step 5, reassessment at 6-8 weeks If it fails at 3 months → discuss injection / ESWT / radiofrequency

A summary algorithm for intervening on the modifiable mechanical factors. Sources: Matthews 2019, Bhatia 2020, Munir 2023.

The foot orthosis with a metatarsal dome deserves a specific mention. Its logic is mechanical: placed behind the metatarsal heads (which demands a precise fitting), it spreads the metatarsal heads apart at every step, which widens the space the nerve passes through and reduces the compression.¹٬⁶ The randomised trial by Saygi et al. (2005, Foot Ankle Int) compared, in 82 patients, a change of footwear with orthoses against a corticosteroid injection: 63 % of the patients in the footwear and orthoses group were completely or partly relieved at 12 months, against 82 % in the injection group, with no statistically significant difference between the two groups at one year.⁶ The effect proper to the dome has not been isolated by a trial comparing a domed insole with a flat one: it remains extrapolated from the mechanical rationale. An important caveat : the precise placement of the dome is crucial, since a poor position cancels the effect. A follow-up at 4-6 weeks for adjustment is recommended.

The key message in practice

In the woman aged 40-60 with a metatarsalgia suggestive of a Morton's neuroma, the most effective, least costly and most reproducible intervention remains a change of footwear. That means:
  • An explicit audit of her shoe collection (at least those worn > 50 % of the time).
  • An education about the mechanism, since adherence is better when the patient understands why her shoes are the cause.
  • An initial trial of 6-8 weeks with suitable footwear before judging conservative treatment a failure.
  • An honest, pragmatic negotiation : it is rarely realistic to impose zero heels. Set priorities: heels kept for short occasions (evenings, events), not for 8 hours of standing work.
  • An ongoing reassessment of footwear whenever it recurs, even late.

Key points

  • 📊 The female to male ratio of ≈ 4:1 reflects a differential exposure to footwear, not an intrinsic anatomical vulnerability.
  • 👠 A high-heeled shoe with a narrow toe combines 3 stresses at once: MTP hyperextension, lateral compression, and raised forefoot pressure (+22 % from 2.5 cm, ~+100 % at 10 cm).
  • 🦶 The footwear audit is the most cost-effective intervention of the physiotherapy consultation when Morton is suspected.
  • 📐 The orthosis with a metatarsal dome is effective if correctly positioned (fitting + adjustment at 4-6 weeks).
  • 🤝 The honest, pragmatic negotiation (heels kept for short occasions) achieves better adherence than an absolute ban.
Bibliography
  1. Bhatia M, Thomson L. Morton's neuroma — Current concepts review. J Clin Orthop Trauma. 2020;11(3):406-409. PMID 32405199.
  2. Mak MS, Chowdhury R, Johnson R. Morton's neuroma: review of anatomy, pathomechanism, and imaging. Clin Radiol. 2021;76(3):235.e15-235.e23. doi:10.1016/j.crad.2020.10.006.
  3. Munir U, Tafti D, Morgan S. Morton Neuroma. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; updated 2023 May. NBK470249.
  4. Lizano-Díez X, Ginés-Cespedosa A, Alentorn-Geli E, Pérez-Prieto D. Morton's interdigital neuroma: instructional review. EFORT Open Rev. 2019;4(1):14-24. doi:10.1302/2058-5241.4.180025.
  5. Frey C, Thompson F, Smith J, Sanders M, Horstman H. American Orthopaedic Foot and Ankle Society women's shoe survey. Foot Ankle. 1993;14(2):78-81. PMID 8454237 [Note: a founding study on the woman-footwear impact, still widely cited].
  6. Saygi B, Yildirim Y, Saygi EK, Kara H, Esemenli T. Morton neuroma: comparative results of two conservative methods. Foot Ankle Int. 2005;26(7):556-559. PMID 16045848.
  7. Matthews BG, Hurn SE, Harding MP, Henderson RA, Lazzarini PA. The effectiveness of non-surgical interventions for common plantar digital compressive neuropathy (Morton's neuroma): a systematic review and meta-analysis. J Foot Ankle Res. 2019;12:12. PMID 30809275.

Which treatment strategies are the most effective for Morton's neuroma?

In this chapter: a five-level treatment pyramid (from conservative to surgery), the aggregated evidence of Matthews 2019 (non-surgical SR/MA), Choi 2021 (corticosteroids), Lu 2021 (injection vs neurolysis vs neurectomy), the 2025 review on radiofrequency, the place of exercise and of ESWT, and patient education. Management is resolutely conservative and progressive.
The management of Morton's neuroma follows a progressive and multimodal model of care, favouring first the least invasive and least risky interventions.¹٬² The meta-analysis by Matthews et al. (2019, J Foot Ankle Res) on 25 studies (7 RCTs + 18 series) confirms that conservative approaches bring significant relief to most patients early in the condition.³

Where do you start? What is the recommended hierarchy of interventions?

The therapeutic approach must follow a clear hierarchy, validated by the main recent reviews.¹٬²٬³

🔺 The treatment pyramid for Morton's neuroma (five levels)

From the most invasive (top) to the most universal (base), with an indicative % of patients concerned

Treatment pyramid for Morton's neuroma ⬆ + invasive ⬇ + universal Surgery (neurectomy) ≈ 10 % After ≥ 6 months of failed conservative care (Lu 2021) ESWT, radiofrequency, cryoablation ≈ 15 % Minimally invasive, SR/MA 2025 favourable to RFA Ultrasound-guided corticosteroid injections ≈ 30 % Effective in the short and medium term (Choi 2021) An orthosis with a metatarsal dome + exercise ≈ 80 % Intrinsic strengthening + gastroc stretching Education + a change of footwear 100 % A non-negotiable universal base (wide toe box, low heel)

A summary pyramid based on the recent systematic reviews. Sources: Matthews 2019, Bhatia 2020, Lu 2021, Choi 2021, RFA SR 2025.

The 1st line rests on two complementary non-invasive interventions:
  • A change of footwear (a wide toe box, a low heel, forefoot cushioning), set out in the previous chapter. It is the most effective and most cost-effective intervention.¹٬⁴
  • A foot orthosis with a metatarsal dome, placed behind the heads to spread them apart and unload the nerve.¹٬²٬⁵ A randomised trial (Saygi 2005, Foot Ankle Int): 63 % complete or partial relief at 12 months with suitable footwear and orthoses, against 82 % after a corticosteroid injection, with no significant difference between the two groups at one year.⁵
This first line must be kept up for ≥ 3 months before considering a more invasive intervention.²٬⁶ Most patients at a mild to moderate stage respond well. The 2nd line is introduced when the 1st line fails:
  • Ultrasound-guided corticosteroid injections : the systematic review by Choi et al. (2021, Clin Orthop Surg) confirms maximal relief between 1 week and 3 months after the injection, with patient satisfaction in the majority on the Johnson score.⁷ Limits: the long-term effect is more debated, and there is a risk of plantar fat pad atrophy (rare but cumulative with repeated injections). Recommendation: limit to 1-3 spaced injections.²٬⁷
  • Sclerosing alcohol injection : the evidence of efficacy is variable; the Pasquali 2015 study (n = 508 patients) shows acceptable satisfaction rates but far from negligible adverse effects (post-injection pain, rarely digital ischaemia).⁸ To be used with caution, by an experienced operator.
The 3rd line brings together the modern minimally invasive techniques:
  • Pulsed or continuous radiofrequency : the systematic review and meta-analysis by Llombart-Blanco et al. (2025, 8 studies, 237 patients) reports a significant reduction in pain at the last follow-up (a mean difference of 5.74 VAS points, 95 % CI 5.58 to 5.90), 47.6 % complete relief (95 % CI 25.1 to 70.0) but 16.4 % of patients with no benefit at all (95 % CI 11.9 to 20.9), for 2.1 % of complications, most of them resolving.⁹ In the sensitivity analyses, protocols of 3 cycles or fewer do better than those of more than 3 cycles, and temperatures ≥ 85 °C better than < 85 °C.⁹
  • ESWT (extracorporeal shockwave therapy) : Seok et al. (2016, JAPMA) ran a placebo-controlled RCT confirming a reduction in VAS and an improvement in AOFAS at 4 weeks.¹⁰ Level of evidence: moderate, with limited data.
  • Guided cryoablation : Cazzato et al. (2016, CVIR), 20 patients, 24 neuromas, 95 % satisfaction at 20 months (a pilot study).¹¹ An emerging technique, to be confirmed.
The surgical option (neurectomy or neurolysis) is reserved for failures of well-conducted conservative treatment over ≥ 6 months. The meta-analysis by Lu et al. (2021, Acta Neurochir) on 35 studies and 2,998 patients reports:¹²
  • Complete resolution of the pain: 43 % after injection, 68 % after neurolysis, 74 % after neurectomy.
  • Complete satisfaction: 35 % after injection, 63 % after neurolysis, 57 % after neurectomy.
  • Major complication: recurrent stump neuroma ≈ 14 % after neurectomy.
A 2023 SR/MA (Zhang J et al, J Foot Ankle Res) on the comparison between the dorsal and the plantar approach for neurectomy finds no significant difference for overall adverse events; the plantar approach has more wound problems, and the dorsal approach is generally preferred first line.¹³

📊 Comparative efficacy: injection vs neurolysis vs neurectomy (Lu 2021, MA n=2998)

The percentage of patients with complete pain resolution and with satisfaction

Comparative efficacy of the treatments after Lu 2021 100% 75% 50% 25% 0% 43 % 35 % Injection 68 % 63 % Neurolysis 74 % 57 % Neurectomy Pain resolution Complete satisfaction

Note: neurectomy carries a risk of a recurrent stump neuroma ≈ 14 % , hence the importance of exhausting conservative care first. Source: Lu VM et al. Acta Neurochir. 2021;163:531-543.

What place does exercise hold and is there a superior approach?

The literature on exercise specific to Morton's neuroma is surprisingly thin. No randomised controlled trial has directly compared exercise protocols; the current recommendations rest on solid but non-randomised biomechanical reasoning. 👟 Three aims clinically justify an exercise programme:
  1. Stretching the gastrocnemius-soleus complex : DiGiovanni et al. (2002, JBJS) showed that isolated gastrocnemius tightness (measured by the Silfverskiöld test) is associated with raised forefoot pressures during walking.¹⁴ Stretching the calf (against a wall, off a step, the Silfverskiöld stretch) is therefore a logical addition.
  2. Strengthening the intrinsic foot muscles : abductor hallucis, the short flexors, the lumbricals. The « short foot » exercise (actively shortening the plantar arch without curling the toes) strengthens the active support of the transverse arch and potentially reduces the dropping of the metatarsal heads.¹٬¹⁵
  3. Mobility of the MTP and intermetatarsal joints : gentle joint mobilisation aimed at keeping the heads moving and avoiding locking in hyperextension. Self-mobilisation by rolling the forefoot on a massage ball is tolerated by most patients.
Worth noting: proximal strengthening (gluteus medius, pelvic control) has an indirect justification in the runner, since a drift into knee valgus or excessive pronation raises the medial stresses on the foot. The programme is to be individualised to the sporting context.

Manual therapy, shockwave, radiofrequency: how effective are they really?

ModalityProposed mechanismLevel of evidencePractical indication
A change of footwearRemoving the mechanical stressHigh (consensus, the base of the 1st line)Always, 1st line
An orthosis with a metatarsal domeDecompression of the interdigital spaceLow to moderate (RCT Saygi 2005, SR Thomson 2020)1st line, combined with the footwear
Exercise (stretching + intrinsics)Reducing the biomechanical stressesLow (biomechanical reasoning, few RCTs)A useful addition, with few adverse effects
Targeted manual therapyIntermetatarsal mobilisation, myofascial releaseLow (a rationale, few specific studies)An adjunct in the physiotherapy clinic
Ultrasound-guided corticosteroid injectionA local anti-inflammatory effectHigh in the short and medium term (Choi 2021)2nd line, ≤ 3 injections
Alcohol sclerosisChemical neurolysisModerate (Pasquali 2015) with adverse events not rareExperienced operators only
ESWT (shockwave)Tissue stimulation, neovascularisationModerate (RCT Seok 2016, limited data)A non-invasive option, 2nd-3rd line
Pulsed or continuous radiofrequencyNerve modulation, partial neurolysisModerate-high (SR/MA 2025, n=237, 47.6 % complete relief, 16.4 % with no benefit)3rd line, an alternative to surgery
CryoablationNeurolysis by coldLow (pilot series, Cazzato 2016)Emerging, to be confirmed
Surgical neurectomyExcision of the neuromaHigh (Lu 2021, 74 % success)A last resort, with a 14 % risk of a recurrent neuroma

Beyond the physical: how do you educate the patient and address psychological factors?

The education of the patient is the cornerstone of treatment. 🧠 The patient must understand:
  • The mechanical nature of the condition (nerve compression, not a tumour); defusing the word « neuroma » is in itself therapeutic.²
  • The causal link footwear → condition: without that understanding, adherence to the changes is poor.¹٬²
  • The realistic expectations : progressive improvement (weeks to months), no « miracle cure ». Early frustration and discouragement hold back compliance.²
  • The importance of a temporary change of activity (reducing running on hard ground, alternating with cycling or swimming), followed by a progressive return.
Psychologically, chronic forefoot pain, in the active woman above all, can generate kinesiophobia, anxiety and avoidance strategies that worsen functional disability. A biopsychosocial approach, reassuring about the benign nature of the condition and encouraging the patient to keep up an adapted activity, is essential. Shared decision-making (Légaré 2018, Cochrane) is central to the choice between prolonged conservative treatment, injection and surgery.¹⁶
« The move from a 1st to a 2nd line of treatment must never be automatic: it must rest on an explicit discussion with the patient about the expected benefits, the risks and their personal preferences. Shared decision-making is non-negotiable before any injection or surgery. »

Criticism and controversies on treatment

Three areas of debate shape current practice: First, the definition of conservative failure remains vague. The recommended durations range from 3 to 12 months across sources, and the objective criteria for moving to the 2nd line are not standardised. That leaves considerable room for clinical judgement and patient preference.²٬⁶ Secondly, the long-term benefit of corticosteroid injections is more debated than their short-term benefit. The cumulative risk of plantar fat pad atrophy, which perpetuates metatarsalgia, justifies limiting the number of injections (≤ 3) and spacing them (≥ 4-6 weeks apart).⁷ Thirdly, the evidence base for exercise is surprisingly weak. Most recommendations rest on coherent biomechanical reasoning rather than on RCTs comparing specific protocols. It is a priority field of research for physiotherapy: a structured protocol (exercise + manual therapy vs an orthosis alone) still needs validating at high quality.

Key points

  • 🥇 The 1st line is conservative : a change of footwear + an orthosis with a metatarsal dome, to be kept up for ≥ 3 months.
  • 💉 The ultrasound-guided corticosteroid injections are effective in the short and medium term (Choi 2021), so limit them to ≤ 3 injections.
  • ⚡ The radiofrequency (SR/MA 2025: 47.6 % complete relief, 16.4 % with no benefit) and the ESWT (RCT Seok 2016) are validated minimally invasive options for the 2nd-3rd line.
  • 🔪 The surgery (neurectomy) offers 74 % success (Lu 2021) but carries a 14 % risk of a recurrent stump neuroma.
  • 🧠 The education and the shared decision-making (Légaré 2018) are non-negotiable pillars before any invasive procedure.
  • 🏋️‍♀️ The exercise (gastrocnemius stretching, intrinsic strengthening) has a solid rationale but a limited evidence base, so use it as an addition.
Bibliography
  1. Bhatia M, Thomson L. Morton's neuroma — Current concepts review. J Clin Orthop Trauma. 2020;11(3):406-409. PMID 32405199.
  2. Munir U, Tafti D, Morgan S. Morton Neuroma. In: StatPearls [Internet]. 2023. NBK470249.
  3. Matthews BG, Hurn SE, Harding MP, Henderson RA, Lazzarini PA. The effectiveness of non-surgical interventions for common plantar digital compressive neuropathy (Morton's neuroma): a systematic review and meta-analysis. J Foot Ankle Res. 2019;12:12. PMID 30809275.
  4. Thomson L, Aujla RS, Divall P, Bhatia M. Non-surgical treatments for Morton's neuroma: A systematic review. Foot Ankle Surg. 2020;26(7):736-743. PMID 31718949.
  5. Saygi B, Yildirim Y, Saygi EK, Kara H, Esemenli T. Morton neuroma: comparative results of two conservative methods. Foot Ankle Int. 2005;26(7):556-559. PMID 16045848.
  6. Valisena S, Petri GJ, Ferrero A. Treatment of Morton's neuroma: A systematic review. Foot Ankle Surg. 2018;24(4):271-281. PMID 29409240.
  7. Choi JY, Lee HI, Hong WH, Suh JS, Hur JW. Corticosteroid Injection for Morton's Interdigital Neuroma: A Systematic Review. Clin Orthop Surg. 2021;13(2):266-277. doi:10.4055/cios20256.
  8. Pasquali C, Vulcano E, Novario R, Varotto D, Montoli C, Volpe A. Ultrasound-guided alcohol injection for Morton's neuroma. Foot Ankle Int. 2015;36(1):55-59. PMID 25367249.
  9. Llombart-Blanco R, Mariscal G, Benlloch M, Barrios C, Llombart-Ais R. Systematic Review and Meta-analysis of Radiofrequency Ablation for Morton's Neuroma: Outcomes and Predictors of Success. Am J Phys Med Rehabil. 2025;104(5):465-472. PMID 39642322.
  10. Seok H, Kim SH, Lee SY, Park SW. Extracorporeal Shockwave Therapy in Patients with Morton's Neuroma: A Randomized, Placebo-Controlled Trial. J Am Podiatr Med Assoc. 2016;106(2):93-99. PMID 27031544.
  11. Cazzato RL, Garnon J, Ramamurthy N, et al. Percutaneous MR-Guided Cryoablation of Morton's Neuroma: Rationale and Technical Details After the First 20 Patients. Cardiovasc Intervent Radiol. 2016;39(10):1396-1402. PMID 27189181.
  12. Lu VM, Puffer RC, Everson MC, Gilder HE, Burks SS, Spinner RJ. Treating Morton's neuroma by injection, neurolysis, or neurectomy: a systematic review and meta-analysis of pain and satisfaction outcomes. Acta Neurochir (Wien). 2021;163(2):531-543. PMID 32056015.
  13. Zhang J, Fu Q, Zhang Y, Tu C, Zhang H. Effect of surgical approach on the treatment of Morton's neuroma: a systematic review and meta-analysis. J Foot Ankle Res. 2023;16:60. PMID 37674248.
  14. DiGiovanni CW, Kuo R, Tejwani N, et al. Isolated gastrocnemius tightness. J Bone Joint Surg Am. 2002;84(6):962-970. PMID 12063330.
  15. Lizano-Díez X, Ginés-Cespedosa A, Alentorn-Geli E, Pérez-Prieto D. Morton's interdigital neuroma: instructional review. EFORT Open Rev. 2019;4(1):14-24. doi:10.1302/2058-5241.4.180025.
  16. Légaré F, Adekpedjou R, Stacey D, et al. Interventions for increasing the use of shared decision making by healthcare professionals. Cochrane Database Syst Rev. 2018;7(7):CD006732. PMID 30025154.

How do you secure a lasting recovery and prevent recurrence in Morton's neuroma?

In this chapter: patient empowerment as the pillar of durability, environmental changes (long-term footwear, weight management, choice of activity), a home exercise programme, and a structured plan for a progressive return to sport guided by pain and by functional capacity.
The durability of the result in Morton's neuroma is not decided during the weeks of active treatment, but in the habits the patient will adopt for the long term. A successful course of rehabilitation that is not followed by a lasting change of footwear will expose the patient to recurrence sooner or later.¹٬² The recovery phase is therefore the moment to anchor secondary prevention behaviours.

How do you make the patient an active player in their own recovery through self-management?

Self-management rests on four complementary pillars:
1A quarterly footwear audit (everyday + work + sport)
≥ 3Months of daily wear of an orthosis with a metatarsal dome
5×/weekGastrocnemius stretching and intrinsic strengthening
< 2/10The VAS threshold on walking before the return to sport
  • A lasting change of footwear 👟: this is the most cost-effective element. The practical rule is: no narrow-toed shoe and no heel > 5 cm in everyday wear. Heels stay reserved for short occasions (≤ 2-3 h now and then). The education stresses negotiation, not an absolute ban, which improves adherence.¹٬²٬³
  • Continuous use of the orthosis with a metatarsal dome in the adapted footwear, for at least 3 months, then according to tolerance and recurrence. It need not be worn permanently for life, but it stays useful for prolonged standing or sporting activity.⁴
  • A home exercise programme 🧘 :
    • Gastrocnemius stretching (against a wall, off a step, 3×30 s, ≥ 5×/week), reference DiGiovanni 2002.⁵
    • Soleus stretching (knee bent, same position).
    • Intrinsic strengthening: the « short foot exercise » (3×10 repetitions per foot, ≥ 4×/week); picking up a towel with the toes; abductor hallucis against a band.¹٬⁶
    • Self-mobilisation of the MTP and intermetatarsal joints by rolling on a massage ball, 1-2 min per foot, after the shower or at the end of the day.
  • Weight and activity management ⚖️: a modest reduction in body weight (5-10 %) significantly lowers plantar pressures. Advise a temporary substitution of high-impact activities (running, dance, jumping) with activities that spare the forefoot (cycling, swimming, cross-trainer) during the acute and transition phases.²

When and how do you plan a safe return to sport and to activity?

The return to sport or to high-impact activity must be progressive, structured and guided by the symptoms. No single standardised protocol exists in the literature, but a consensus emerges on the principles of progression, valid for most foot and ankle conditions.²

📅 A plan for a progressive return to activity, five steps

Criteria for moving to the next step: pain ≤ 2/10 during the activity, no worsening at 24-48 h

Progressive return-to-sport plan in Morton Step 1 Daily life Walking, ADLs VAS < 2/10 Step 2 Low impact Cycling, swimming 2-3×/week 30 min Step 3 Moderate loads Brisk walking, cross-trainer Step 4 Controlled impact Running alternating walk and run Step 5 Performance ↑ volume then intensity ⏱️ Typical total duration: 6-12 weeks Criterion for moving on: VAS ≤ 2/10 during the activity AND no worsening at 24-48 h 🚦 If the pain recurs: step back one level, wear the orthosis permanently A running footwear audit is COMPULSORY (wide toe box, drop ≤ 8 mm, forefoot cushioning)

A plan adapted from the general principles of return to musculoskeletal activity (a narrative consensus). Sources: Bhatia 2020, Munir 2023.

The steps in detail:
  1. Step 1, controlled daily life : a prerequisite before any return to activity. The pain must be ≤ 2/10 on normal walking in suitable shoes. If that criterion is not met, the work stays centred on the 1st line (footwear + orthosis + home exercise).
  2. Step 2, reintroducing low-impact activities 🚴: swimming (preferred, as it puts no load on the forefoot), cycling (check the position of the foot on the pedal, avoid clip pedals that squeeze the forefoot), light cross-trainer. 2-3 sessions of 30 min a week, pain-free.
  3. Step 3, moderate loads : brisk walking on a treadmill or a soft trail, a more intense cross-trainer. Prerequisite: keeping to the VAS < 2/10 criterion. Always in wide shoes + the orthosis.
  4. Step 4, the return to impact 🏃: running is reintroduced very gradually. A walk-run programme: start with 1 min running / 4 min walking, ×5-8 repetitions, 2×/week. Prefer soft ground (a tartan track, an earth trail) before asphalt. Increase the volume before the intensity.
  5. Step 5, the return to performance : a progressive increase in weekly volume (the +10 % per week rule), then the introduction of intensity (intervals, fast pace). A continuous check: if the pain recurs, step back one level for 1-2 weeks before progressing again.

🚩 Warning signs during the return to sport

  • A return of burning or electric-shock pain in the forefoot → go back to the previous step, check the footwear, wear the orthosis systematically.
  • Pain persisting > 48 h after the activity → a signal that the load exceeds the tissue capacity; reduce the volume.
  • New oedema or swelling → have a bursitis, a stress fracture or an inflammatory reaction in another joint ruled out.
  • Pain at night or at rest → reconsider the diagnosis; a medical consultation to exclude an alternative condition.
  • Early recurrence despite suitable footwear and an orthosis → discuss a 2nd line of treatment (injection, ESWT, radiofrequency).

Criticism and controversies on recovery

Three areas of debate persist in the literature: First, although orthoses with a metatarsal dome are widely recommended, there is no clear standardisation of their optimal design (dome size, density, precise position). Some of the variability in clinical results follows from that.²٬⁴ Clinical follow-up with adjustment at 4-6 weeks remains the best guarantee of efficacy. Secondly, the literature badly lacks return-to-sport protocols specific to Morton. The current recommendations rest on general principles of musculoskeletal progression, not on dedicated studies. The pain thresholds, transition durations and objective criteria for progressing still need validating. Thirdly, the threshold for conservative failure before considering a 2nd or 3rd line remains imprecise. The recommended durations range from 3 to 12 months across studies and schools of thought.²٬⁷ Clinical common sense prevails: a patient at a moderate to severe stage with a marked impact can justify accelerating towards an injection, without waiting 6 months of conservative care if quality of life is severely affected.

Key points

  • 🏠 The lasting recovery is decided in the long term through self-management : suitable footwear, wearing the orthosis, home exercises.
  • 📉 The return to sport must be progressive (five steps), guided by a VAS ≤ 2/10 and by the absence of worsening at 24-48 h.
  • 🚴 Favour swimming and cycling in the transition, before reintroducing impact activities (alternating walking and running).
  • 👟 The audit of sports footwear is compulsory (a wide toe box, a drop ≤ 8 mm, forefoot cushioning).
  • 🚦 If it recurs: step back one level, wear the orthosis permanently, and discuss a 2nd line if it recurs repeatedly despite good compliance.
Bibliography
  1. Bhatia M, Thomson L. Morton's neuroma — Current concepts review. J Clin Orthop Trauma. 2020;11(3):406-409. PMID 32405199.
  2. Munir U, Tafti D, Morgan S. Morton Neuroma. In: StatPearls [Internet]. 2023. NBK470249.
  3. Lizano-Díez X, Ginés-Cespedosa A, Alentorn-Geli E, Pérez-Prieto D. Morton's interdigital neuroma: instructional review. EFORT Open Rev. 2019;4(1):14-24. doi:10.1302/2058-5241.4.180025.
  4. Matthews BG, Hurn SE, Harding MP, Henderson RA, Lazzarini PA. The effectiveness of non-surgical interventions for common plantar digital compressive neuropathy (Morton's neuroma): a systematic review and meta-analysis. J Foot Ankle Res. 2019;12:12. PMID 30809275.
  5. DiGiovanni CW, Kuo R, Tejwani N, et al. Isolated gastrocnemius tightness. J Bone Joint Surg Am. 2002;84(6):962-970. PMID 12063330.
  6. Jain S, Mannan K. The diagnosis and management of Morton's neuroma: a literature update. Foot Ankle Spec. 2013;6(4):307-317. PMID 23811947.
  7. Thomson L, Aujla RS, Divall P, Bhatia M. Non-surgical treatments for Morton's neuroma: A systematic review. Foot Ankle Surg. 2020;26(7):736-743. PMID 31718949.

What do real clinical cases teach us about Morton's neuroma?

In this chapter: three clinical archetypes useful for anchoring practice. Rather than lending ages and figures to fictional patients, we describe typical profiles (supported by published clinical series) and a published case series verified on PubMed on what a mechanical examination adds in a confirmed neuroma. Three questions structure these cases: how a « simple » case evolves under conservative treatment; how a diagnosis goes wrong; how to handle a complex case (recurrence, multiple neuromas).

Analysis of a « classic » case: from assessment to conservative resolution

An archetypal profile (a composite of the clinical series published in Bhatia 2020 and Munir 2023): a woman in her fifties, a professional standing 8 hours a day, regularly wearing narrow-toed shoes with a medium heel (4-6 cm), consults for a burning pain in the 3rd intermetatarsal space of the right foot, present for 8 months. The pain is intermittent, triggered by her work shoes, relieved immediately by taking the shoe off. The sensation of « walking on a pebble » is reported spontaneously.¹٬² On examination:
  • Inspection: moderate bilateral hallux valgus, no swelling.
  • Palpation: reproducible focal pain in the 3rd space, no bone pain.
  • Mulder test : a palpable click, reproducing the typical pain → strongly suggestive (high specificity).³
  • No red flag.
High-resolution ultrasound confirms a non-compressible hypoechoic mass of 6 mm in the 3rd space, compatible with a Morton's neuroma. No notable associated bursitis.⁴ Initial management (1st line, to be kept up for ≥ 3 months):
  • A change of footwear : dropping the narrow-toed work shoes; buying shoes with a wide toe box + forefoot cushioning.
  • A foot orthosis with a metatarsal dome placed behind heads 3 and 4 (follow-up at 4 weeks for adjustment).
  • A home exercise programme : gastrocnemius stretching 3×30 s, ×5/week; short foot exercise 3×10 per foot, ×4/week; self-mobilisation with a ball at the end of the day.
  • Education : an explanation of the mechanism, defusing the word « neuroma », realistic expectations (progressive improvement over 2-3 months).
The typical course at 6-12 weeks: partial improvement in most (40-60 %) patients at a mild to moderate stage (Matthews 2019, SR/MA).⁵ If the pain persists at 3 months despite good compliance, an ultrasound-guided corticosteroid injection can be proposed. The Lizano-Díez 2017 RCT (FAI, n = 41) showed that a series of 3 corticosteroid + anaesthetic injections brings not significant advantage over the anaesthetic alone at 3-6 months, though in the shorter term (1-3 months) the benefit is shown in other series.⁶٬⁷ The discussion of the benefit-risk balance must be explicit. The practical outcome in this kind of profile: ~70-80 % of patients are lastingly relieved by the combination of footwear + orthosis + 1-2 injections, with no need for surgery.² Recurrence is generally linked to a return to « unsuitable » shoes.

The diagnostic challenge: when Morton's neuroma mimics another condition

Classic traps in practice (a synthesis of Mahadevan 2015, Pitcher 2024):
  • Metatarsal stress fracture : forefoot pain in a runner, similar in location. The distinction: the fracture is more painful on focal bone palpation, persists at rest, and imaging (a repeat radiograph at 2 weeks or an early MRI) confirms it.³٬⁸
  • Intermetatarsal bursitis : a very close picture, sometimes associated. Ultrasound tells the two apart (a bursitis is a compressible anechoic structure; a neuroma is a non-compressible hypoechoic mass).⁴
  • MTP capsulitis or synovitis : pain that is more dorsal and focal over the MTP joint, a positive drawer sign, sometimes a floating toe. To be considered for the 2nd MTP joint in particular.
  • Freiberg's disease : osteonecrosis of the metatarsal head, most often M2, in the adolescent girl or young adult. Diagnostic imaging (radiograph, MRI).
  • L5-S1 radiculopathy : pain referred from the lumbar spine, with a spinal examination and a straight leg raise to include.
  • Peripheral diabetic neuropathy : to be considered in the patient with diabetes and diffuse stocking hypoaesthesia.
A published case series: the mechanical management of a confirmed Morton : Post and Maccio reported in the Journal of Manual & Manipulative Therapy (2020) a series of three women aged 54 to 75, referred by a podiatrist with a Morton's neuroma established on imaging and provocation tests, assessed and treated by mechanical diagnosis and therapy (MDT): repeated end-range movements chosen by directional preference, at the lumbar spine in one patient and at the distal extremity in the other two, gave immediate and one-year results the authors described as excellent, for 2 to 3 sessions per patient.⁹ A series of three cases with no control group demonstrates no efficacy: it indicates only that a mechanical examination deserves to be carried out before considering an invasive procedure. Targeted manual therapy remains thinly supported: the Matthews meta-analysis (2019) retains only one controlled trial of manipulation and mobilisation in Morton's neuroma, favourable on the VAS (a mean reduction of 15.3 points, 95 % CI: 1.0 to 29.6).⁵ ⚠️ A practical lesson : faced with forefoot pain initially treated as a Morton's neuroma that does not improve in 6-8 weeks despite footwear + orthosis + exercise, the diagnosis must be reconsidered : review the imaging, exclude a stress fracture (radiograph + MRI if in doubt), a capsulitis, Freiberg's disease, or a systemic condition.

A complex case: stump recurrence and multiple forms

Two particular clinical situations deserve attention: 1. The recurrent stump neuroma after neurectomy is a dreaded but documented complication. The meta-analysis by Lu et al. (2021, Acta Neurochir, n = 2,998) reports an incidence of ≈ 14 % stump neuroma after neurectomy.¹⁰ The mechanism: the divided nerve stump regrows in a disorganised way, forming a genuine and very painful « stump neuroma », often harder to treat than the original one. Clinically: the pain returns a few months after initially satisfactory surgery, sometimes more intense, sometimes with a marked neuropathic component (allodynia, dysaesthesia). MRI or ultrasound confirms a fibrous scar mass at the operative site. Revision surgery (often by the dorsal approach, sometimes burying the stump in a muscle or a bone) is an option, but with a more modest success rate.¹⁰٬¹¹ Techniques of injecting the stump (corticosteroid, alcohol) or of pulsed radiofrequency can be tried before a further operation.
« The 14 % risk of a recurrent stump neuroma after neurectomy (Lu 2021) is the strongest argument for exhausting conservative treatment before considering surgery. That information must be shared explicitly with the patient in the shared decision. »
2. Multiple or bilateral neuromas are rarer (estimated at < 5 % of cases).² The presentation is often less focal: diffuse forefoot pain, several spaces involved, difficulty identifying one predominant space clinically. Bilateral and multi-space ultrasound is essential for mapping the lesions. Management requires:
  • An analysis of the mechanical factors in detail : a markedly cavus or flat foot, an associated deformity, chronically unsuitable footwear.
  • An ordering of priorities : treat the most symptomatic and disabling space first.
  • An in-depth discussion about surgery: excising several nerves at once or in stages, the cumulative risk of complications, the loss of interdigital sensation.

Criticism: what clinical cases do and do not say

Published clinical cases are instructive but carry important limits 💡:
  • They often represent « interesting » cases or therapeutic successes ; the failures are under-represented. Publication bias probably overestimates the efficacy of the interventions.
  • The anatomical-clinical correlation stays imperfect : Bencardino (2000) documented ≈ 33 % compatible images in asymptomatic people.¹² Finding a « neuroma » on imaging in a patient in pain does not prove causation, hence the importance of clinical and imaging coherence.
  • The surgical option, despite high satisfaction rates (74 %), carries non-trivial complications (14 % recurrent stump neuroma, loss of interdigital sensation).¹⁰ The decision must always be shared and informed.
  • The emerging techniques (pulsed radiofrequency, cryoablation) show promising results but often rest on small series (n=20-50). Confirmation by larger RCTs is needed.

Key points

  • 📋 The typical case (a woman of 40-60, unsuitable footwear, the 3rd space, Mulder +) is generally resolved by footwear + an orthosis + ± an injection.
  • 🎭 The differential diagnosis is essential: if there is no improvement in 6-8 weeks, reconsider (stress fracture, bursitis, Freiberg, capsulitis).
  • 🔄 The recurrent stump neuroma affects ≈ 14 % of those operated on (Lu 2021), a strong argument for exhausting conservative care.
  • 👯 The multiple or bilateral forms (< 5 %) complicate management and call for complete imaging and a more cautious surgical discussion.
  • 🤝 The shared decision and transparency about the risks are non-negotiable before any surgery.
Bibliography
  1. Munir U, Tafti D, Morgan S. Morton Neuroma. In: StatPearls [Internet]. 2023. NBK470249.
  2. Bhatia M, Thomson L. Morton's neuroma — Current concepts review. J Clin Orthop Trauma. 2020;11(3):406-409. PMID 32405199.
  3. Pitcher M, Moulson A, Pitcher D, Herbland A, Cairns MC. Diagnostic Accuracy of Subjective Features and Physical Examination Tests for Morton Neuroma: A Systematic Review. Foot Ankle Orthop. 2024;9(4). doi:10.1177/24730114241291055.
  4. Bignotti B, Signori A, Sormani MP, Molfetta L, Martinoli C, Tagliafico A. Ultrasound versus magnetic resonance imaging for Morton neuroma: systematic review and meta-analysis. Eur Radiol. 2015;25(8):2254-2262. PMID 25809742.
  5. Matthews BG, Hurn SE, Harding MP, Henderson RA, Lazzarini PA. The effectiveness of non-surgical interventions for common plantar digital compressive neuropathy (Morton's neuroma): a systematic review and meta-analysis. J Foot Ankle Res. 2019;12:12. PMID 30809275.
  6. Lizano-Díez X, Ginés-Cespedosa A, Alentorn-Geli E, et al. Corticosteroid Injection for the Treatment of Morton's Neuroma: A Prospective, Double-Blinded, Randomized, Placebo-Controlled Trial. Foot Ankle Int. 2017;38(9):944-951. PMID 28617064.
  7. Choi JY, Lee HI, Hong WH, Suh JS, Hur JW. Corticosteroid Injection for Morton's Interdigital Neuroma: A Systematic Review. Clin Orthop Surg. 2021;13(2):266-277. doi:10.4055/cios20256.
  8. Mahadevan D, Venkatesan M, Bhatt R, Bhatia M. Diagnostic accuracy of clinical tests for Morton's neuroma compared with ultrasonography. J Foot Ankle Surg. 2015;54(4):549-553. doi:10.1053/j.jfas.2014.09.021.
  9. Post MD, Maccio JR. Mechanical diagnosis and therapy and Morton's neuroma: a case-series. J Man Manip Ther. 2020;28(1):60-67. PMID 31177965 [case series accessible in PMC].
  10. Lu VM, Puffer RC, Everson MC, Gilder HE, Burks SS, Spinner RJ. Treating Morton's neuroma by injection, neurolysis, or neurectomy: a systematic review and meta-analysis of pain and satisfaction outcomes. Acta Neurochir (Wien). 2021;163(2):531-543. PMID 32056015.
  11. Zhang J, Fu Q, Zhang Y, Tu C, Zhang H. Effect of surgical approach on the treatment of Morton's neuroma: a systematic review and meta-analysis. J Foot Ankle Res. 2023;16:60. PMID 37674248.
  12. Bencardino J, Rosenberg ZS, Beltran J, Liu X, Marty-Delfaut E. Morton's neuroma: is it always symptomatic? AJR Am J Roentgenol. 2000;175(3):649-653. PMID 10954445.

How do you apply these recommendations concretely in your practice?

In this chapter: triage of the red flags (Finucane 2020), identifying the psychosocial yellow flags, targeted interprofessional referral (physician, radiologist, podiatrist, orthopaedic surgeon, psychologist), standardised outcome measurement (validated PROMs MOXFQ / FFI / AOFAS), shared decision-making (Légaré 2018, Cochrane) and lifting the barriers to implementing evidence-based practice.
Applying the recommendations concretely in Morton's neuroma calls for two distinct skills: knowing how to refer at the right moment to the right people, and measuring outcomes reproducibly in order to adapt management. Expert practice is also built on the ability to overcome the systemic obstacles to implementation.

When, and to which other health professionals, should you refer?

One of the fundamental skills of the first-line physiotherapist is the ability to recognise the situations that lie beyond their scope. Three categories of flag structure that decision: Red flags 🚩: they indicate a potentially serious condition and call for prompt medical referral. The international IFOMPT 2020 framework (Finucane et al, JOSPT) remains the reference for assessing musculoskeletal red flags.¹ The red flags specific to the painful forefoot were set out in chapter 2. No single sign has a strong predictive value: it is the combination of signs and the overall clinical context that point the way.² Yellow flags ⚠️: psychosocial factors that predict chronicity, catastrophising, kinesiophobia, mistaken beliefs about pain, depressive symptoms, low self-efficacy. In the context of Morton's neuroma these factors are frequent in working women who are exposed (standing, sport) and see their quality of life affected. A biopsychosocial approach (pain education, cognitive restructuring, encouragement to keep up an adapted activity) is essential. When yellow flags predominate and persist despite physiotherapy, refer to a psychologist trained in chronic pain or to a pain physician.³ Targeted interprofessional referral 🤝, according to the picture:
Clinical situationRecommended referralWhy
A red flag (night pain, a history of cancer, fever…)GP / emergency departmentExcluding a serious condition before management
Persistent diagnostic doubt or failure at 6-8 weeksSports physician / orthopaedic foot surgeonFurther imaging, differential diagnosis
Ultrasound or MRI neededMusculoskeletal radiologistHigh-resolution ultrasound / targeted MRI
A custom orthosis to be madePodiatrist / orthotistA personalised adaptation of the metatarsal dome
A corticosteroid injection neededRheumatologist or interventional radiologistAn ultrasound-guided procedure for precision
Conservative failure ≥ 6 months, a surgical indicationOrthopaedic foot surgeonDiscussion of neurectomy / minimally invasive techniques
Marked kinesiophobia or catastrophisingPsychologist trained in painCBT, chronic pain management
Significant excess weight, metabolic comorbiditiesNutrition physician / GPOverall management of weight and of diabetes where present

How do you measure outcomes and overcome the barriers to implementation?

To make sure the interventions are effective and appropriate, it is essential to measure outcomes objectively and reproducibly. 📈 Validated outcome measures (PROMs) relevant to Morton's neuroma :
  • Visual Analogue Scale (VAS) 0-10 for pain: simple, quick, sensitive to change. To be measured at rest, on walking, and during a provocative activity.
  • MOXFQ (Manchester-Oxford Foot Questionnaire) : 16 items, 3 subscales (pain, walking and standing, social), validated for surgical and conservative foot and ankle pathology.
  • FFI (Foot Function Index) : 23 items, 3 dimensions (pain, disability, activity limitation), widely used internationally.
  • AOFAS Forefoot : a composite score (clinician + patient), 100 points. Criticised for its unbalanced subjective-to-objective ratio, but still much used in orthopaedics.
  • Goal Attainment Scaling (GAS) : Krasny-Pacini et al. proposed a reference methodological update (2013, Ann Phys Rehabil Med), useful for quantifying the achievement of the patient's personal goals.⁴
  • Tampa Scale of Kinesiophobia (TSK) : if a yellow flag is suspected.
A practical recommendation : use at a minimum the VAS + 1 functional PROM (MOXFQ or FFI as preferred), at 3 time points (baseline, an interim point at 4-6 weeks, and the end). That makes it possible:
  • To document the objective course.
  • To detect a failure or a plateau early.
  • To justify the benefit-to-cost balance to the patient and to the funders.
  • To take part in aggregating data for research.
Shared decision-making (SDM) 🤝: the Cochrane review by Légaré et al. (2018) confirms that interventions promoting SDM improve treatment adherence and patient satisfaction.⁵ SDM is particularly relevant in Morton :
  • The choice between continuing conservative care or an injection at 3-6 months.
  • The choice between an injection, radiofrequency, cryoablation or surgery when it fails.
  • An explicit discussion of the risk of a recurrent stump neuroma (14 %) before surgery (Lu 2021).⁶
Barriers to implementing evidence-based practice 🚧: The classic barriers identified in physiotherapy are stable across the literature: a lack of time, a lack of research skills, a lack of organisational support, limited access to databases. For Morton specifically, further obstacles are frequently cited:
  • Availability of ultrasound : variable between settings, which holds back diagnostic confirmation.
  • The cost of custom orthoses : reimbursement varies between countries and can limit access.
  • The small number of RCTs specific to Morton : the evidence base for exercise and manual therapy stays limited, which makes standardising protocols harder.
  • Waiting times for specialists (interventional radiology, foot surgery) in some health systems.
Strategies for lifting these obstacles :
  • Easier access to evidence summaries (PubMed, Cochrane, JOSPT, BJSM, EFORT Open Reviews, the last of which offers freely accessible reviews, including the Lizano-Díez 2019 instructional review).⁷
  • Peer mentoring and taking part in communities of practice (learned societies, online case groups).
  • Continuous updating : subscribing to PubMed alerts for « Morton's neuroma » and « interdigital neuropathy » filtered on SR/MA.
  • Systematically building a PROM into the patient record, a benefit that accumulates from patient to patient.
  • Recognising the limits and referring early when a case goes beyond the scope of 1st line physiotherapy.

Critique and controversies: beyond the guidelines

Applying the recommendations rigidly can carry risks. Three nuances deserve to be stressed: First, the « red flag paradox » : looking for them is non-negotiable for safety, but an excessive focus can induce a nocebo effect and lead to costly and often useless imaging cascades.² The expert skill lies in the ability to interpret the flags in their clinical context, not in identifying them mechanically. Secondly, the « PROM implementation gap » : having dozens of validated questionnaires is not enough if their use stays superficial (ticking the box without interpreting it). Building them into the clinical workflow and using the results to guide the decision are the real added value. Thirdly, the standardisation versus individualisation tension : practice guides rest on statistical averages, but the patient sitting in front of us has their own comorbidities, social context and preferences. The expertise lies in adapting the recommendations, not applying them mechanically. The evidence is a map 🗺️; the patient and the context are the compass.
« The best management of Morton's neuroma is rarely the one that follows the recommendations most rigidly: it is the one that combines a clear evidence-based framework, with a careful ear for the patient's preferences, and the clear-sightedness to refer when the case goes beyond our scope. »

Key points

  • 🚩 Identifying the red flags (Finucane 2020) calls for prompt medical referral; identifying the yellow flags (kinesiophobia, catastrophising) justifies psychological collaboration.
  • 📊 Measure outcomes with at a minimum the VAS + 1 PROM (MOXFQ or FFI) at 3 time points (baseline, interim, final).
  • 🤝 The shared decision-making (Légaré 2018, Cochrane) is central to the choice between conservative, injection and surgical care.
  • 🌐 Structured interprofessional collaboration (radiologist, podiatrist, surgeon, psychologist) improves the patient's pathway.
  • 🚧 The barriers to implementation are systemic (time, access, training), and lifting them goes through mentoring, access to evidence summaries, and the routine use of PROMs.
  • ⚖️ Expert practice navigates between standardisation (the recommendations) and individualisation (patient preferences), making an absolute of neither.
Bibliography
  1. Finucane LM, Downie A, Mercer C, et al. International Framework for Red Flags for Potential Serious Spinal Pathologies. J Orthop Sports Phys Ther. 2020;50(7):350-372. PMID 32438853.
  2. Cook CE, George SZ, Reiman MP. Red flag screening for low back pain: nothing to see here, move along: a narrative review. Br J Sports Med. 2018;52(8):493-496. PMID 28923844.
  3. Vlaeyen JWS, Crombez G, Linton SJ. The fear-avoidance model of pain. Pain. 2016;157(8):1588-1589. PMID 27428892.
  4. Krasny-Pacini A, Hiebel J, Pauly F, Godon S, Chevignard M. Goal attainment scaling in rehabilitation: a literature-based update. Ann Phys Rehabil Med. 2013;56(3):212-230. PMID 23562111.
  5. Légaré F, Adekpedjou R, Stacey D, et al. Interventions for increasing the use of shared decision making by healthcare professionals. Cochrane Database Syst Rev. 2018;7(7):CD006732. PMID 30025154.
  6. Lu VM, Puffer RC, Everson MC, Gilder HE, Burks SS, Spinner RJ. Treating Morton's neuroma by injection, neurolysis, or neurectomy: a systematic review and meta-analysis of pain and satisfaction outcomes. Acta Neurochir (Wien). 2021;163(2):531-543. PMID 32056015.
  7. Lizano-Díez X, Ginés-Cespedosa A, Alentorn-Geli E, Pérez-Prieto D. Morton's interdigital neuroma: instructional review. EFORT Open Rev. 2019;4(1):14-24. doi:10.1302/2058-5241.4.180025.
  8. Bhatia M, Thomson L. Morton's neuroma — Current concepts review. J Clin Orthop Trauma. 2020;11(3):406-409. PMID 32405199.

What next after reading this?

This article is part of a collection of evidence-based clinical syntheses. A question, a comment, a correction to suggest? Contact us directly through the WhatsApp button at the bottom right of the screen.

↑ Back to contents PubMed sources

Physio Learning · Evidence-based clinical syntheses

This article has undergone a rigorous bibliographic check: every reference cited carries a PubMed PMID or a verified CrossRef DOI. The figures and the statements are sourced. The clinical cases cited are drawn from the published literature.

Last revisedMay 2026 MethodologyA synthesis of meta-analyses + international consensus statements Level of evidenceMixed (from level 1a meta-analyses to level 5 case reports, ranked within the article) Conflicts of interestNone declared A question, or an error to report?WhatsApp button at the bottom right of the screen 💬

Behind this article

An author who explains, a reviewer who checks.

How we write and check our content

Anthony Baillon, physiotherapist and co-founder of Physio Learning
✍️ Author

Anthony Baillon

Physiotherapist · co-founder of Physio Learning

Marked for life by his first four-hour lecture without a single image, he took a master’s in instructional design so that it would never happen to anyone again. He hunts down publication bias and unreadable slides with the same intransigence.

PhysiotherapistInstructional designerCare design
Follow on LinkedIn
Robin Vervaeke, head of scientific content at Physio Learning✓ Checked

Robin Vervaeke

Scientific lead

Physiotherapist specialising in neuro-musculoskeletal practice and holder of a master’s in public health. He checks the methodological rigour of every article: primary sources, levels of evidence, no exceptions.

NeuromusculoskeletalMaster's in public health
Follow on LinkedIn

Also worth reading in the review

Share